National Health Issues Survey Results
Access & Affordability
Results from national survey on health issues including patient access and affordability, drug pricing policies, and trust among healthcare stakeholders. This report – the first of three – explores the results on the issues of access and affordability.
Current Issues Report #4
Questions decisionmakers should ask
ICER’s value assessment framework is intended to support recommendations for pricing and affordability. That means ICER must be held responsible for the credibility of its claims.
Current Issues Report #3
The standards of normal science: pseudoscience in health technology assessment
The methods espoused by groups such as ICER to support model claims fail the standards of normal science and should be rejected.
Current Issues Report #2
Capturing the patient voice in value assessment: needs fulfillment
A key component of any value assessment framework is the patient voice as an accurate, quantifiable, understandable measure that reflects the benefit to the patient rather than the interest of clinicians.
Current Issues Report #1
Abandoning QALYs: an unnecessary distraction in value assessment
The QALY measure failes to capture the patient voice in assessing value.